{
    "nctId": "NCT01271959",
    "briefTitle": "A Study of ChemoFx\u00ae Chemoresponse Assay in Solid Tumors - ChemoFx\u00ae Registry Study",
    "officialTitle": "A Multicenter, Post-Market Follow-up Study of ChemoFx\u00ae Chemoresponse Assay in Solid Tumors - ChemoFx\u00ae Registry Study",
    "overallStatus": "TERMINATED",
    "conditions": "Solid Organ Tumors",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 167,
    "primaryOutcomeMeasure": "To determine physicians' rate of compliance with ChemoFx assay results in the treatment of subjects with solid tumors.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Pathologically confirmed diagnosis of solid tumor malignancy;\n* Medically indicated to receive chemotherapy;\n* Fresh tissue submitted from the solid tumor malignancy for testing with the ChemoFx\u00ae assay after August, 2006;\n* Final ChemoFx\u00ae assay report is available;\n* Subject must be at least 18 years of age;\n* Subject must sign and date an IRB approved ICF.\n\nExclusion Criteria:\n\n* Enrolled in PT-103, PT-106, PT-206, PT-301, or PT-304;\n* Pregnant or lactating subjects;\n* Subjects are not indicated to receive chemotherapy for their disease;\n* Subjects with psychiatric or addictive disorders that would preclude obtaining informed consent.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}